Consistent with the Immunohistochemistry (IHC) results (Figure 6G), the expression of MDC1, PSMB1, PSMD2, PSMD7 and PSMD14 were significant augmented in breast cancer patients (P < 0.05). This evidence concerns the gene PSMD7 and breast carcinoma.